Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb…
Xencor, Inc. a clinical-stage biopharmaceutical company developing engineered monoclonal antibodies and cytokines for the treatment of cancer and autoimmune diseases, announced an…
Read More...
Read More...
